Kathryn A. Peterson
( out of 95 reviews )

Kathryn A. Peterson, MD, MSci

Languages spoken: English

Clinical Locations

Farmington Health Center

801-213-3200

University of Utah Hospital

Gastroenterology Endoscopy Center
801-213-9797

  • Kathryn Peterson, MD is Professor of Gastroenterology at University of Utah Health. She is certified by the American Board of Internal Medicine.

    Dr. Peterson specializes in diagnosing and treating diseases of the digestive system including Eosiniphilic Esophagitis, Barrett’s Esophagus, and inflammatory bowel disease. She completed her medical degree at the University of Texas Southwestern, followed by residency and a fellowship at the University of Utah and a masters program in Epidemiology at Harvard University.

    Specialties

    Patient Rating

    4.9 /5
    ( out of 95 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    September 25, 2023
    UH HOSPITALS AND CLINICS

    Truly the best of the best. I am so very grateful to have her on my team!

    September 14, 2023
    UH HOSPITALS AND CLINICS

    Dr Petersen is knowledgeable about my EOE, gastritis and colitis, and listens to my concerns and questions. I do feel as if she does care about the impact of these conditions on my everyday life. She is willing to discuss treatment options and isnt dismissive of my opinions.

    September 14, 2023
    UH HOSPITALS AND CLINICS

    Dr. Peterson and her crew are by far the best group of physicians I have ever worked with at the U. She really cares for her patients and is very attentive to each individual need. I would highly recommended Dr. Peterson, I feel she is one of, if not the best out there with her specializations. I feel very lucky to have her as my Doctor. Thank you.

    September 14, 2023
    UH HOSPITALS AND CLINICS

    Kathryn Peterson is very knowledgeable and probes with really good probing questions to determine what I need/want to improve my health. I appreciate her personalized approach and the extra time she took to explain my EOS problem and what might be triggering it. Most importantly, even though we just met as patient/physician, I felt Kathryn cares a lot about me.

    September 08, 2023
    UH HOSPITALS AND CLINICS

    Dr. Peterson is the first GI to help figure out my stomach pain instead of just blaming it on reflux. She works with me to find solutions and fix the root cause of the pain. She has been wonderful to work with and I highly recommend her.

    July 13, 2023
    UH HOSPITALS AND CLINICS

    Dr. Peterson listened to me and made me feel cared about. Shes incredible.

    June 26, 2023
    UH HOSPITALS AND CLINICS

    Dr. Peterson has been my EoE doctor now for many years, even when i don't see her for two years, she always remembers my case, and is knowledgeable about the symptoms I have, and doesn't waste time by asking me the "getting to know you" questions, because she remembers me to begin with.

    June 21, 2023
    UH HOSPITALS AND CLINICS

    Seeing doctors is not high on my list of favorite things to do! Dr. Peterson has been a wonderful doctor with each of the visits and conversations I have had with her. I feel very confident in her ability to manage my health issues, and I appreciate her ability to communicate on a down-to-earth level. Thank You Dr. Peterson!

    June 21, 2023
    UH HOSPITALS AND CLINICS

    Dr. Peterson is a phenomenal doctor. She takes the time to address my questions and concerns. She also found the issue that was going on with me and has provided a treatment plan and continued monitoring that has improved my condition.

    See More Patient Comments

  • Kathryn Peterson, MD is Professor of Gastroenterology at University of Utah Health. She is certified by the American Board of Internal Medicine.

    Dr. Peterson specializes in diagnosing and treating diseases of the digestive system including Eosiniphilic Esophagitis, Barrett’s Esophagus, and inflammatory bowel disease. She completed her medical degree at the University of Texas Southwestern, followed by residency and a fellowship at the University of Utah and a masters program in Epidemiology at Harvard University.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Dermatology -Adjunct
    Academic Divisions Gastroenterology

    Education history

    Graduate Training Epidemiology - Harvard University M.Sci.
    Gastroenterology - University of Utah School of Medicine Fellow
    Residency Internal Medicine - University of Utah School of Medicine Resident
    Internal Medicine - University of Utah School of Medicine Intern
    Professional Medical Medicine - University of Texas Southwestern M.D.
    Molecular Biology - Texas Tech University B.S.
    Undergraduate University of Delaware

    Selected Publications

    Journal Article

    1. Dellon ES, Peterson KA, Mitlyng BL, Iuga A, Bookhout CE, Cortright LM, Walker KB, Gee TS, McGee SJ, Cameron BA, Galanko JA, Woosley JT, Eluri S, Moist SE, Hirano I (2023). Mepolizumab for treatment of adolescents and adults with eosinophilic oesophagitis: a multicentre, randomised, double-blind, placebo-controlled clinical trial. Gut, 72(10), 1828-1837.
    2. Toy G, Colletier K, Hale G, Valentine J, Gawron AJ, Sossenheimer M, Peterson K, Aparicio R, Fang JC (2023). Incidence of retained biopsy specimens after esophagogastroduodenoscopy and colonoscopy. Endosc Int Open, 11(7), E653-E659.
    3. Dellon ES, Peterson KA, Mitlyng BL, Iuga A, Bookhout CE, Cortright LM, Walker KB, Gee TS, McGee SJ, Cameron BA, Galanko JA, Woosley JT, Eluri S, Moist SE, Hirano I (2023). Mepolizumab for treatment of adolescents and adults with eosinophilic oesophagitis: a multicentre, randomised, double-blind, placebo-controlled clinical trial. Gut, 72(10), 1828-1837.
    4. Reddy CA, Allen-Brady K, Uchida AM, Peterson KA, Hoffman AM, Souza RF, Spechler SJ (2023). Achalasia is Strongly Associated with Eosinophilic Esophagitis and Other Allergic Disorders. Clin Gastroenterol Hepatol.
    5. Kliewer KL, Gonsalves N, Dellon ES, Katzka DA, Abonia JP, Aceves SS, Arva NC, Besse JA, Bonis PA, Caldwell JM, Capocelli KE, Chehade M, Cianferoni A, Collins MH, Falk GW, Gupta SK, Hirano I, Krischer JP, Leung J, Martin LJ, Menard-Katcher P, Mukkada VA, Peterson KA, Shoda T, Rudman Spergel AK, Spergel JM, Yang GY, Zhang X, Furuta GT, Rothenberg ME (2023). One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial. Lancet Gastroenterol Hepatol.
    6. Talley NJ, Peterson KA, Genta RM, Chang AT, Dellon ES, Sandborn WJ, 019 Study Team (2022). High discovery rate of duodenal and gastric eosinophilia in patients with unexplained moderate-severe abdominal symptoms: A prospective US multi-site study. Gastroenterology, 164(4), 680-683.e2.
    7. Leiman DA, Kamal AN, Otaki F, Bredenoord AJ, Dellon ES, Falk GW, Fernandez-Becker NQ, Gonsalves N, Hirano I, Katzka DA, Peterson K, Yadlapati R, Kathpalia P (2022). Quality Indicators for the Diagnosis and Management of Eosinophilic Esophagitis. Am J Gastroenterol.
    8. Chang JW, Kliewer K, Katzka DA, Peterson KA, Gonsalves N, Gupta SK, Furuta GT, Dellon ES (2022). Provider Beliefs, Practices, and Perceived Barriers to Dietary Elimination Therapy in Eosinophilic Esophagitis. Am J Gastroenterol, 117(12), 2071-2074.
    9. Pyne AL, Hazel MW, Uchida AM, Qeadan F, Jordan KC, Holman A, Harward B, Gleich GJ, Peterson KA (2022). Oesophageal secretions reveal local food-specific antibody responses in eosinophilic oesophagitis. Aliment Pharmacol Ther, 56(9), 1328-1336.
    10. Allen-Brady K, Colletier KJ, Woller S, Eliason K, Uchida AM, Ro G, Newman M, Peterson KA (2022). Eosinophilic Gastritis and Enteritis Are Increased in Families with Eosinophilic Esophagitis. Am J Gastroenterol, 118(2), 263-268.
    11. Uchida AM, Ro G, Qiang L, Peterson KA, Round J, Dougan M, Dougan SK (2022). Human differentiated eosinophils release IL-13 in response to IL-33 stimulation. Front Immunol, 13, 946643.
    12. Parbhu SK, Shah SC, Sossenheimer MJ, Fang JC, Peterson KA, Gawron AJ (2022). Index diagnoses of gastric intestinal metaplasia in the United States: patient characteristics, endoscopic findings, and clinical practice patterns at a large tertiary care center. Therap Adv Gastroenterol, 15, 17562848221117640.
    13. Chang JW, Kliewer K, Katzka DA, Peterson KA, Gonsalves N, Gupta SK, Furuta GT, Dellon ES (2022). Provider beliefs, practices, and perceived barriers to dietary elimination therapy in eosinophilic esophagitis. Am J Gastroenterol, 117(12), 2071-2074.
    14. Dellon ES, Khoury P, Muir AB, Liacouras CA, Safroneeva E, Atkins D, Collins MH, Gonsalves N, Falk GW, Spergel JM, Hirano I, Chehade M, Schoepfer AM, Menard-Katcher C, Katzka DA, Bonis PA, Bredenoord AJ, Geng B, Jensen ET, Pesek RD, Feuerstadt P, Gupta SK, Lucendo AJ, Genta RM, Hiremath G, McGowan EC, Moawad FJ, Peterson KA, Rothenberg ME, Straumann A, Furuta GT, Aceves SS (2022). A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. Gastroenterology.
    15. Dellon ES, Khoury P, Muir AB, Liacouras CA, Safroneeva E, Atkins D, Collins MH, Gonsalves N, Falk GW, Spergel JM, Hirano I, Chehade M, Schoepfer AM, Menard-Katcher C, Katzka DA, Bonis PA, Bredenoord AJ, Geng B, Jensen ET, Pesek RD, Feuerstadt P, Gupta SK, Lucendo AJ, Genta RM, Hiremath G, McGowan EC, Moawad FJ, Peterson KA, Rothenberg ME, Straumann A, Furuta GT, Aceves SS (2022). A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. J Allergy Clin Immunol.
    16. Peterson K, Clayton F, Qeadan F, Gorman D, Robson J, Allen-Brady K, Fang JC (2020). Esophageal Eosinophilia Is Common Among Relatives of Eosinophilic Esophagitis Patients. Clin Gastroenterol Hepatol, 20(5), e957-e963.
    17. Qeadan F, Tingey B, Egbert J, Pezzolesi MG, Burge MR, Peterson KA, Honda T (2022). The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: A nationwide cohort from the US using the Cerner Real-World Data. PLoS One, 17(4), e0266809.
    18. Dellon ES, Gonsalves N, Abonia JP, Alexander JA, Arva NC, Atkins D, Attwood SE, Auth MKH, Bailey DD, Biederman L, Blanchard C, Bonis PA, Bose P, Bredenoord AJ, Chang JW, Chehade M, Collins MH, Di Lorenzo C, Dias JA, Dohil R, Dupont C, Falk GW, Ferreira CT, Fox AT, Genta RM, Greuter T, Gupta SK, Hirano I, Hiremath GS, Horsley-Silva JL, Ishihara S, Ishimura N, Jensen ET, Gutirrez-Junquera C, Katzka DA, Khoury P, Kinoshita Y, Kliewer KL, Koletzko S, Leung J, Liacouras CA, Lucendo AJ, Martin LJ, McGowan EC, Menard-Katcher C, Metz DC, Miller TL, Moawad FJ, Muir AB, Mukkada VA, Murch S, Nhu QM, Nomura I, Nurko S, Ohtsuka Y, Oliva S, Orel R, Papadopoulou A, Patel DA, Pesek RD, Peterson KA, Philpott H, Putnam PE, Richter JE, Rosen R, Ruffner MA, Safroneeva E, Schreiner P, Schoepfer A, Schroeder SR, Shah N, Souza RF, Spechler SJ, Spergel JM, Straumann A, Talley NJ, Thapar N, Vandenplas Y, Venkatesh RD, Vieira MC, von Arnim U, Walker MM, Wechsler JB, Wershil BK, Wright BL, Yamada Y, Yang GY, Zevit N, Rothenberg ME, Furuta GT, Aceves SS (2022). International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature. Clin Gastroenterol Hepatol.
    19. Ma C, Bredenoord AJ, Dellon ES, Alexander JA, Biedermann L, Hogan M, Guizzetti L, Zou G, Katzka DA, Chehade M, Falk GW, Furuta GT, Gupta SK, Kagalwalla AF, Schoepfer AM, Miehlke S, Moawad FJ, Peterson K, Gonsalves NP, Straumann A, Wechsler JB, Rmillard J, Shackelton LM, Almonte HS, Feagan BG, Jairath V, Hirano I (2022). Reliability and responsiveness of endoscopic disease activity assessment in eosinophilic esophagitis. Gastrointest Endosc.
    20. Rothenberg ME, Hottinger SKB, Gonsalves N, Furuta GT, Collins MH, Talley NJ, Peterson K, Menard-Katcher C, Smith M, Hirano I, Genta RM, Chehade M, Gupta SK, Spergel JM, Aceves SS, Dellon ES (2021). Impressions and aspirations from the FDA GREAT VI Workshop on Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis and Perspectives for Progress in the Field. J Allergy Clin Immunol.
    21. Zimmermann N, Abonia JP, Dreskin SC, Akin C, Bolton S, Happel CS, Geller M, Larenas-Linnemann D, Nanda A, Peterson K, Wasan A, Wechsler J, Zhang S, Bernstein JA (2021). Developing a standardized approach for assessing mast cells and eosinophils on tissue biopsies: A Work Group Report of the AAAAI Allergic Skin Diseases Committee. J Allergy Clin Immunol.
    22. Peterson K, Safroneeva E, Schoepfer A (2021). Emerging Therapies for Eosinophilic Gastrointestinal Diseases. J Allergy Clin Immunol Pract.
    23. COREOS Collaborators, Ma C, Schoepfer AM, Dellon ES, Bredenoord AJ, Chehade M, Collins MH, Feagan BG, Furuta GT, Gupta SK, Hirano I, Jairath V, Katzka DA, Pai RK, Rothenberg ME, Straumann A, Aceves SS, Alexander JA, Arva NC, Atkins D, Biedermann L, Blanchard C, Cianferoni A, Ciriza de Los Rios C, Clayton F, Davis CM, de Bortoli N, Dias JA, Falk GW, Genta RM, Ghaffari G, Gonsalves N, Greuter T, Hopp R, Hsu Blatman KS, Jensen ET, Johnston D, Kogalwalla AF, Larsson HM, Leung J, Louis H, Masterson JC, Menard-Katcher C, Menard-Katcher PA, Moawad FJ, Muir AB, Mukkada VA, Penagini R, Pesek RD, Peterson K, Putnam PE, Ravelli A, Savarino EV, Schlog C, Schreiner P, Simon D, Smyrk TC, Spergel JM, Taft TH, Terrehorst I, Vanuytsel T, Venter C, Vieira MC, Vieth M, Vlieg-Boerstra B, von Arnim U, Walker MM, Wechsler JB, Woodland P, Woosley JT, Yang GY, Zevit N, Safroneeva EJ (2021). Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS) PMID: 34242635. Clin Immunol.
    24. Dellon ES, Gonsalves N, Rothenberg ME, Hirano I, Chehade M, Peterson KA, Falk GW, Murray JA, Gehman LT, Chang AT, Singh B, Rasmussen HS, Genta RM (2021). Determination of Biopsy Yield That Optimally Detects Eosinophilic Gastritis and/or Duodenitis in a Randomized Trial of Lirentelimab. Clin Gastroenterol Hepatol, 20(3), 535-545.e15.
    25. Ravi A, Marietta EV, Alexander JA, Peterson K, Lavey C, Geno DM, Murray JA, Katzka DA (2020). Mucosal penetration and clearance of gluten and milk antigens in eosinophilic oesophagitis. Aliment Pharmacol Ther, 53(3), 410-417.
    26. Dellon ES, Peterson KA, Murray JA, Falk GW, Gonsalves N, Chehade M, Genta RM, Leung J, Khoury P, Klion AD, Hazan S, Vaezi M, Bledsoe AC, Durrani SR, Wang C, Shaw C, Chang AT, Singh B, Kamboj AP, Rasmussen HS, Rothenberg ME, Hirano I (2020). Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis. N Engl J Med, 383(17), 1624-1634.
    27. DeLay K, Pandolfino JE, Gyawali CP, Frye J, Kaizer A, Menard-Katcher P, Sloan JA, Gawron AJ, Peterson K, Carlson DA, Khan A, Keswani RN, Yadlapati R (2020). Esophageal Manometry Competency Program Improves Gastroenterology Fellow Performance in Motility Interpretation. Am J Gastroenterol, 115(9), 1453-1459.
    28. Peterson K, Lin E, Saffari H, Qeadan F, Pyne A, Firszt R, Robson J, Gleich G (2020). Food-specific antibodies in oesophageal secretions: association with trigger foods in eosinophilic oesophagitis. Aliment Pharmacol Ther, 52(6), 997-1007.
    29. Peterson KA, Gleich GJ, Limaye NS, Crispin H, Robson J, Fang J, Saffari H, Clayton F, Leiferman KM (2019). Eosinophil granule major basic protein 1 deposition in eosinophilic esophagitis correlates with symptoms independent of eosinophil counts. Dis Esophagus, 32(11).
    30. Hirano I, Dellon ES, Hamilton JD, Collins MH, Peterson K, Chehade M, Schoepfer AM, Safroneeva E, Rothenberg ME, Falk GW, Assouline-Dayan Y, Zhao Q, Chen Z, Swanson BN, Pirozzi G, Mannent L, Graham NMH, Akinlade B, Stahl N, Yancopoulos GD, Radin A (2019). Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis. Gastroenterology.
    31. Youngblood BA, Brock EC, Leung J, Falahati R, Bochner BS, Rasmussen HS, Peterson K, Bebbington C, Tomasevic N (2019). Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis. JCI Insight, 4(19).
    32. McClain A, OGorman M, Barbagelata C, Patel R, Lowichik A, Peterson K, Guthery S, Robson J (2019). Adherence to Biopsy and Follow-Up Guidelines in a Population-Based Cohort of Children With Eosinophilic Esophagitis. Clin Gastroenterol Hepatol, 18(11), 2620-2622.
    33. Robson J, Korgenski K, Parsons K, McClain A, Barbagelata C, Allen-Brady K, Patel R, OGorman M, Peterson K, Guthery S (2019). Sensitivity and Specificity of Administrative Medical Coding for Pediatric Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr, 69(2), e49-e53.
    34. Robson J, Laborda T, Fitzgerald S, Andersen J, Peterson K, OGorman M, Guthery S, Bennett-Murphy L (2019). Avoidant/Restrictive Food Intake Disorder in Diet-treated Children With Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr, 69(1), 57-60.
    35. Siebermair J, Suksaranjit P, McGann CJ, Peterson KA, Kheirkhahan M, Baher AA, Damal K, Wakili R, Marrouche NF, Wilson BD (2019). Atrial fibrosis in non-atrial fibrillation individuals and prediction of atrial fibrillation by use of late gadolinium enhancement magnetic resonance imaging. J Cardiovasc Electrophysiol, 30(4), 550-556.
    36. Robson J, OGorman M, McClain A, Mutyala K, Davis C, Barbagelata C, Wheeler J, Firszt R, Smith K, Patel R, Peterson K, Lowichik A, Guthery S (2018). Incidence and Prevalence of Pediatric Eosinophilic Esophagitis in Utah Based on a 5-Year Population-Based Study. Clin Gastroenterol Hepatol, 17(1), 107-114.e1.
    37. Johnson J, Affolter K, Boynton K, Chen X, Valentine J, Peterson K (2017). CMV Disease in IBD: Comparison of Diagnostic Tests and Correlation with Disease Outcome. Inflamm Bowel Dis, 24(7), 1539-1546.
    38. Laing P, Bress AP, Fang J, Peterson K, Adler DG, Gawron AJ (2017). Trends in diagnoses after implementation of the Chicago classification for esophageal motility disorders (V3.0) for high-resolution manometry studies. Dis Esophagus, 30(12), 1-6.
    39. Martin L, Mullaney S, Peche W, Peterson K, Chan S, Morton R, Wan Y, Zhang C, Presson AP, Emery B, Aston K, Jenkins T, Carrell D, Hotaling J (2017). Population-based Semen Analysis Results and Fertility Among Patients With Inflammatory Bowel Disease: Results From Subfertility Health Assisted Reproduction and the Environment (SHARE) Study. Urology, 107, 114-119.
    40. Frech TM, Fakoya L, Gawron AJ, Wong J, Scholand MB, Sawitzke A, Peterson K (2017). Oesophageal disease in systemic sclerosis: does heritability play a role? Clin Exp Rheumatol, 35 Suppl 106(4), 86-88.
    41. Allred D, Frech TM, McComber C, Peterson K, Ortiz G, McNeill C, Broadbent L, Elorreaga N, Miller T, Scholand MB (2019). Chronic Multiorgan Rare Disease: The Role of the Nurse Practitioner as a Leader of the Healthcare Team. J Med Pract Manage, 32(6), 413-416.
    42. Peterson K, Firszt R, Fang J, Wong J, Smith KR, Brady KA (2016). Risk of Autoimmunity in EoE and Families: A Population-Based Cohort Study. Am J Gastroenterol, 111(7), 926-32.
    43. Padia R, Curtin K, Peterson K, Orlandi RR, Alt J (2016). Eosinophilic esophagitis strongly linked to chronic rhinosinusitis. Laryngoscope, 126(6), 1279-83.
    44. Saffari H, Kennedy A, Peterson KA, Gleich GJ, Pease LF 3rd (2015). Non-invasive ultrasound to identify eosinophil granule proteins in eosinophilic esophagitis. Ultrasound Med Biol, 41(3), 884-9.
    45. Peterson KA, Boynton KK (2013). Which patients with eosinophilic esophagitis (EoE) should receive elemental diets versus other therapies? Curr Gastroenterol Rep, 16(1), 364.
    46. Faigel DO, Eisen GM, Baron TH, Dominitz JA, Goldstein JL, Hirota WK, Jacobson BC, Johanson JF, Leighton JA, Mallery JS, Peterson KA, Raddawi HM, Varg JJ 2nd, Waring JP, Fanelli RD, Wheeler-Harbough J, Standards of Practice Committee American Society for Gastrointestinal Endoscopy (2003). Tissue sampling and analysis. Gastrointest Endosc, 57(7), 811-6.
    47. Faigel DO, Baron TH, Goldstein JL, Hirota WK, Jacobson BC, Johanson JF, Leighton JA, Mallery JS, Peterson KA, Waring JP, Fanelli RD, Wheeler-Harbaugh J, Standards Practice Committe American Society for Gastrointestinal Endoscopy (2002). Guidelines for the use of deep sedation and anesthesia for GI endoscopy. Gastrointest Endosc, 56(5), 613-7.

    Review

    1. Chang JW, Kliewer K, Haller E, Lynett A, Doerfler B, Katzka DA, Peterson KA, Dellon ES, Gonsalves N, Consortium of Eosinophilic Gastrointestinal Disease Researchers (2023). Development of a practical guide to implement and monitor diet therapy for eosinophilic esophagitis. [Review]. Clin Gastroenterol Hepatol.
    2. Uchida AM, Ro G, Garber JJ, Peterson KA, Round JL (2022). Models and Tools for Investigating Eosinophilic Esophagitis at the Bench. [Review]. Front Immunol, 13, 943518.

    Conference Proceedings

    1. Ma C, Schoepfer AM, Safroneeva E, COREOS Collaborators, COREOS Collaborators (2021). Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS): An International Multidisciplinary Consensus. Gastroenterology, United States, 161(3), 748-755.

    Commentary

    1. Ma C, Schoepfer AM, Safroneeva E, COREOS Collaborators (2021). A Summary of the Meetings of the Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS) International Multidisciplinary Consensus. Gastroenterology, 161(3), 778-784.

    Editorial

    1. Gupta SK, Falk GW, Aceves SS, Chehade M, Collins MH, Dellon ES, Gonsalves N, Hirano I, Mukkuda VA, Peterson KA, Spergel J, Yang GY, Furuta GT, Rothenberg ME, Consortium of Eosinophilic Gastrointestinal Disease Researchers CEGIR (2018). Consortium of Eosinophilic Gastrointestinal Disease Researchers: Advancing the Field of Eosinophilic GI Disorders Through Collaboration. Gastroenterology, 156(4), 838-842.

    Letter

    1. Spechler SJ, Reddy CA, Allen-Brady K, Uchida AM, Peterson KA, Hoffman AM, Souza RF (2023). Reply. [Letter to the editor]. Clin Gastroenterol Hepatol.
    2. May Maestas M, Perry KD, Smith K, Firszt R, Allen-Brady K, Robson J, Joy E, Peterson K (2019). Food impactions in Eosinophilic esophagitis and acute exposures to fine particulate pollution. [Letter to the editor]. Allergy, 74(12), 2529-2530.

    Other

    1. Chen JW, Vela MF, Peterson KA, Carlson DA (2023). AGA Clinical Practice Update on the Diagnosis and Management of Extraesophageal Gastroesophageal Reflux Disease: Expert Review. Clin Gastroenterol Hepatol (21(6), pp. 1414-1421.e3). United States.
    2. Aceves SS, Alexander JA, Baron TH, Bredenoord AJ, Day L, Dellon ES, Falk GW, Furuta GT, Gonsalves N, Hirano I, Konda VJA, Lucendo AJ, Moawad F, Peterson KA, Putnam PE, Richter J, Schoepfer AM, Straumann A, McBride DL, Sharma P, Katzka DA (2022). Endoscopic approach to eosinophilic esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference. Gastrointest Endosc. United States.
    3. Hirano I, Collins MH, King E, Sun Q, Chehade M, Abonia JP, Bonis PA, Capocelli KE, Dellon ES, Falk GW, Gonsalves N, Gupta SK, Leung J, Katzka D, Menard-Katcher P, Khoury P, Klion A, Mukkada VA, Peterson K, Shoda T, Rudman-Spergel AK, Spergel JA, Yang GY, Rothenberg ME, Aceves SS, Furuta GT, CEGIR investigators (2021). Prospective Endoscopic Activity Assessment for Eosinophilic Gastritis in a Multisite Cohort. Am J Gastroenterol (117(3), pp. 413-423). United States.
    4. COREOS Collaborators, Ma C, Schoepfer AM, Dellon ES, Bredenoord AJ, Chehade M, Collins MH, Feagan BG, Furuta GT, Gupta SK, Hirano I, Jairath V, Katzka DA, Pai RK, Rothenberg ME, Straumann A, Aceves SS, Alexander JA, Arva NC, Atkins D, Biedermann L, Blanchard C, Cianferoni A, Ciriza de Los Rios C, Clayton F, Davis CM, de Bortoli N, Dias JA, Falk GW, Genta RM, Ghaffari G, Gonsalves N, Greuter T, Hopp R, Hsu Blatman KS, Jensen ET, Johnston D, Kagalwalla AF, Larsson HM, Leung J, Louis H, Masterson JC, Menard-Katcher C, Menard-Katcher PA, Moawad FJ, Muir AB, Mukkada VA, Penagini R, Pesek RD, Peterson K, Putnam PE, Ravelli A, Savarino EV, Schlag C, Schreiner P, Simon D, Smyrk TC, Spergel JM, Taft TH, Terreehorst I, Vanuytsel T, Venter C, Vieira MC, Vieth M, Vlieg-Boerstra B, von Arnim U, Walker MM, Wechsler JB, Woodland P, Woosley JT, Yang GY, Zevit N, Safroneeva E (2021). Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS). J Allergy Clin Immunol (149(2), pp. 659-670). United States.
    5. Qeadan F, Chehade M, Tingey B, Egbert J, Dellon ES, Peterson KA (2021). Patients with eosinophilic gastrointestinal disorders have lower in-hospital mortality rates related to COVID-19. J Allergy Clin Immunol Pract (9(12), pp. 4473-4476.e4). United States.
    6. Saffari H, Peterson KA, Leiferman KM, Stabin MG, Krstyen JJ, Clayton FC, Pease LF 3rd, Yap JT, Hoffman JM, Gleich GJ (2019). Oral Administration of 99mTechnetium-Labeled Heparin in Eosinophilic Esophagitis. Mayo Clin Proc (95(3), pp. 449-458). England.

    Patent

    1. Pease LF, Saffari H, Gleich GJ, Leiferman KM, Peterson KA, Condie RM (2017). Methods for diagnosing and monitoring eosinophilic esophagitis. U.S. Patent No. 10,376,602. Washington, D.C.:U.S. Patent and Trademark Office.
    2. Pease LF, Saffari H, Gleich GJ, Leiferman KM, Peterson KA, Condie RM (2013). Methods for diagnosing and monitoring eosinophilic esophagitis. U.S. Patent No. 9,789,212. Washington, D.C.:U.S. Patent and Trademark Office.